Enlivex Therapeutics Ltd. Quarterly Assets, Current in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Enlivex Therapeutics Ltd. quarterly Assets, Current history and growth rate from Q4 2013 to Q2 2024.
  • Enlivex Therapeutics Ltd. Assets, Current for the quarter ending June 30, 2024 was $28.6M, a 7.2% decline year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $28.6M -$2.22M -7.2% Jun 30, 2024 6-K 2024-08-30
Q4 2023 $33.8M -$18.6M -35.5% Dec 31, 2023 6-K 2024-08-30
Q2 2023 $30.8M -$34.3M -52.7% Jun 30, 2023 6-K 2023-09-01
Q4 2022 $52.3M -$34.1M -39.5% Dec 31, 2022 20-F 2024-04-30
Q2 2022 $65.1M -$27.8M -29.9% Jun 30, 2022 6-K 2022-08-22
Q4 2021 $86.4M +$48.3M +127% Dec 31, 2021 20-F 2023-04-10
Q2 2021 $92.8M +$58.5M +170% Jun 30, 2021 6-K 2021-08-06
Q4 2020 $38.1M +$21.7M +132% Dec 31, 2020 20-F 2022-04-29
Q2 2020 $34.3M Jun 30, 2020 6-K/A 2020-10-13
Q4 2019 $16.4M +$6.14M +59.8% Dec 31, 2019 20-F 2021-04-30
Q4 2018 $10.3M +$6.66M +184% Dec 31, 2018 20-F 2020-04-30
Q4 2017 $3.62M -$6.92M -65.6% Dec 31, 2017 20-F/A 2020-01-23
Q4 2016 $10.5M -$9.85M -48.3% Dec 31, 2016 20-F 2018-04-23
Q4 2015 $20.4M -$12.5M -38% Dec 31, 2015 20-F 2017-02-24
Q4 2014 $32.9M +$32.6M +10898% Dec 31, 2014 20-F 2016-03-29
Q4 2013 $299K Dec 31, 2013 20-F 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.